Clinical Scorecard: Assessment of the effectiveness and safety of vismodegib for treating periocular and orbital basal cell carcinoma: a systematic review and meta-analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Adults with locally advanced or metastatic BCC not candidates for surgery or radiotherapy
Care Setting
Key Highlights
recurrence_rate
Guideline-Based Recommendations
Diagnosis
Diagnosis of periocular and orbital BCC should be confirmed histologically.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Vismodegib may allow for globe preservation and reduce the need for exenteration.
Clinical Best Practices
Careful patient selection is crucial to optimize outcomes with vismodegib.
Consider neoadjuvant use of vismodegib to reduce tumor burden prior to surgery.
Educate patients on potential adverse effects and the importance of monitoring.
